Nuron Biotech Receives Pennsylvania Bio's 2013 Deal of the Year Award for Advancing Bioscience Industry  
3/18/2013 10:04:27 AM

EXTON, Pa.--(BUSINESS WIRE)--Nuron Biotech, Inc., a specialty biologics and vaccines company, was presented with the 2013 Bio Deal of the Year Award by Pennsylvania Bio for the company’s acquisition of Meningitec™ from Pfizer and its financing deal securing funding from Healthcare Royalty Partners II, LP. The Deal of the Year award was presented to Nuron Biotech President, CEO and Founder Shankar Musunuri, PhD, MBA, in recognition of Nuron Biotech’s deals “that resulted in continued growth and advancement of Pennsylvania’s bioscience industry.”